Company Data
Design Therapeutics Inc.
Ticker
DSGN
Current Price
$15.11 -0.92%
Market Cap
$945.6M
Price Target
Refer to Report
Volume
820.8K
52wk Range
$5.04 - $17.25
Overview
Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.